Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by TD Securities and TD Cowen. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by TD Securities and TD Cowen or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Building One Of Biotech's Next Bellwethers: CEO Alexander Hardy & CFO Brian Mueller's Strategy To Grow BioMarin

8:16
 
Share
 

Manage episode 473926906 series 3276203
Content provided by TD Securities and TD Cowen. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by TD Securities and TD Cowen or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Recorded on 03/05/25

TD Cowen analyst Phil Nadeau speaks with BioMarin's CEO Alexander Hardy and CFO Brian Mueller from TD Cowen's 45th Annual Health Care Conference about their vision for one of the biotech industry's fastest-growing mid-cap companies. Alexander and Brian describe how BioMarin will harness innovation to bring transformational therapies to patients while remaining commercially competitive and focused on creating value for shareholders. BioMarin has a well-defined long-term strategy, and has been uniquely transparent about its long-term financial guidance. Alexander and Brian talk about how the company is executing toward its long-term goals while working to convince skeptical investors of its opportunities and under-appreciated strengths. They provide insights into how one of biotech's next bellwethers is being built.

https://go.td.com/PodcastDisclosure

  continue reading

277 episodes

Artwork
iconShare
 
Manage episode 473926906 series 3276203
Content provided by TD Securities and TD Cowen. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by TD Securities and TD Cowen or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Recorded on 03/05/25

TD Cowen analyst Phil Nadeau speaks with BioMarin's CEO Alexander Hardy and CFO Brian Mueller from TD Cowen's 45th Annual Health Care Conference about their vision for one of the biotech industry's fastest-growing mid-cap companies. Alexander and Brian describe how BioMarin will harness innovation to bring transformational therapies to patients while remaining commercially competitive and focused on creating value for shareholders. BioMarin has a well-defined long-term strategy, and has been uniquely transparent about its long-term financial guidance. Alexander and Brian talk about how the company is executing toward its long-term goals while working to convince skeptical investors of its opportunities and under-appreciated strengths. They provide insights into how one of biotech's next bellwethers is being built.

https://go.td.com/PodcastDisclosure

  continue reading

277 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Listen to this show while you explore
Play